
Advancing Science. Improving Connections.
Zynerba is an orphan-focused, neuropsychiatric, biopharmaceutical company taking a different and exciting transdermal approach to cannabinoids.


Our People
Focusing on the unmet medical needs of patients with rare disorders and their families

Our Company
Progressing our mission to improve the lives of patients battling certain rare conditions
Latest News
Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
Read MoreZynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights
Read MoreZynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg Conference
Read More